Purpose. The aim of the present study is to demonstrate the efficacy of HyBeNX® to decontaminate the implant surface, both in the case mucositis and severe peri-implantitis and to allow future bone regeneration.
Materials and methods. We describe three case reports of peri-implantitis successfully treated with HyBeNX®. In our study, we have used microbiological tests to demonstrate the efficacy of HyBeNX® in decreasing bacterial load.
Results. The microbiological results of the clinical cases described show that there was a reduction in the total bacterial count after treatment.
Conclusions. The ability of HyBeNX® to dry the surface and remove biofilm may explain the efficacy of the decontamination and subsequent clinical improvements in all three cases.